AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
METHOCARBAMOL
19 registrations across 9 African markets— 16 active
Markets with METHOCARBAMOL
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| MYLOSPAS TABLET, COATED; ORAL | 🇿🇼Zimbabwe | AUSTELL PHARMACEUTICALS (PTY) LTD | active | Dec 2030 |
| Dorbaxin Tablet Tablet | 🇳🇬Nigeria | Xcel Pharmaceutical Limited | active | Jan 2030 |
| Kinthomol Tablets** Tablet | 🇳🇬Nigeria | Kingzy Pharmaceuticals Limited | active | Jul 2029 |
| Disfor 500 mg Tablet** Tablet | 🇳🇬Nigeria | Faes Farma Nigeria Limited | active | May 2029 |
| MYLOSPAS | 🇿🇦South Africa | Austell Pharmaceuticals (Pty) Ltd | active | Nov 2028 |
| Methocarbamol 500 Tablet** Tablet | 🇳🇬Nigeria | First J. Pocco Pharmacy Limited | active | Dec 2026 |
| Methocarbamol Tablets** Tablet | 🇳🇬Nigeria | Visko Pharmacy Ltd | active | May 2026 |
| LUMIRELAX 500MG COMPRIME BOITE DE 20 | 🇨🇮Côte d'Ivoire | LABORATOIRES JUVISE PHARMACEUTICALS | expired | Dec 2023 |
| ORTOTON Comprimé pelliculé / 750 mg | 🇹🇳Tunisia | OPALIA PHARMA | expired | Feb 2021 |
| ORTOTON Comprimé pelliculé / 750 mg | 🇹🇳Tunisia | OPALIA PHARMA | expired | Feb 2021 |
| METHOCARBAMOL ORAL SOLID
ORDINARY TABLETS | 🇺🇬Uganda | FAES FARMA S.A | active | — |
| DISFOR 500MG CP BTE(2 X 10) FAES FARMA Comprimé, boîte de 2 blisters | 🇲🇬Madagascar | FAES FARMA, S.A. | active | — |
| DISFOR 500MG CP BTE(2 X 10) FAES FARMA Comprimé, boîte de 2 blisters | 🇲🇬Madagascar | FAES FARMA, S.A. | active | — |
| Disfor Oral tablet | 🇹🇿Tanzania | Faes Farma, S.A | active | — |
| METHOCARBAMOL ORAL SOLID
ORDINARY
TABLETS | 🇺🇬Uganda | FAES FARMA S.A | active | — |
| METHOCARBAMOL ORAL SOLID
ORDINARY
TABLETS | 🇺🇬Uganda | FAES FARMA S.A | active | — |
| METHOCARBAMOL ORAL SOLID
ORDINARY TABLETS | 🇺🇬Uganda | FAES FARMA S.A | active | — |
| LUMIRELAX comprimé / 500mg | 🇸🇳Senegal | JUVISE PHARMACEUTICALS | active | — |
| Distem Tablets | 🇹🇿Tanzania | Faes Farma, S.A | active | — |
METHOCARBAMOL in Africa — Regulatory Overview
METHOCARBAMOL is registered across 9 African markets with 19 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Nigeria, Uganda, Tanzania, Madagascar and 5 more. AfricaRegulatory refreshes this data daily from official government sources.
Of the 19 registrations, 16 (84%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.